Associate Professor of Pathology at Massachusetts General Hospital and Harvard Medical School
Institute Member at the Broad Institute of MIT and Harvard
Co-Leader, DF/HCC Neuro-Oncology Program
Co-Director, Cancer Program, Harvard Stem Cell Institute
Mario Suvà is a physician-scientist in the Department of Pathology at Massachusetts General Hospital (MGH) and at the Broad Institute of MIT and Harvard. Dr. Suvà’s expertise is in neuro-oncology, single-cell genomics and chromatin analysis.
Dr. Suvà's laboratory focuses on the biology of brain tumors, both in adults and children. A particular effort of the laboratory is on dissecting the heterogeneity of diffuse gliomas and relating transcriptional and genetic programs of individual cancer cells. Dr. Suvà directed landmark studies characterizing glioblastoma, oligodendroglioma, astrocytoma, pediatric gliomas and medulloblastoma with single-cell genomic technologies, shedding light on tumor heterogeneity, tumor classification, glioma cell lineages, cancer stem cell programs, tumor evolution and the composition of the tumor microenvironment.
Dr. Suvà obtained his Ph.D. in Lausanne, Switzerland, studying cancer stem cells in gliomas and sarcomas. He earned his M.D. from the University of Lausanne and his certification in Neuropathology from the Swiss Medical Association. He did his post-doctoral research at MGH and the Broad Institute, applying chromatin analysis and functional approaches to identify master regulators of glioma stem cell programs.
Steps to claim CME credits for BWH Neurology Grand Rounds 2020-2021:
Text this code "GUDSUP” to 1-857-214-2277.
- A link will be sent to your email. Click on the link and complete the evaluation. After you complete the evaluation, your CME will be recorded. You will then be able to download a PDF of your certificate.
If you have any questions about the CME credit, please contact Partners Office of Continuing Professional Development at PartnersCPD@partners.org.
